superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2016-12-31
- Valid until
- 2017-12-31
- Published
- 2017-02-09
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 2,075,142,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals research and development: 2,052,295,000 United States dollar", as of 2016-12-31 (until 2017-12-31). Claim clm_0710977E9941, https://asof.is/claim/clm_0710977E9941, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm.
APA
AsOf. (2016). Regeneron Pharmaceuticals research and development: 2,052,295,000 United States dollar (as of 2016-12-31 (until 2017-12-31)) [Record clm_0710977E9941]. Retrieved November 9, 2026, from https://asof.is/claim/clm_0710977E9941 (source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm)
BibTeX
@misc{asof_clm_0710977E9941,
author = {AsOf},
title = {Regeneron Pharmaceuticals research and development: 2,052,295,000 United States dollar},
year = {2016},
howpublished = {\url{https://asof.is/claim/clm_0710977E9941}},
note = {Claim clm\_0710977E9941, as of 2016-12-31 (until 2017-12-31); source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_0710977E9941.md/v1/claims/clm_0710977E9941submit a correction